Acute Gouty Arthritis Clinical Trial
Official title:
A Randomized, Double-blind, Active-controlled Study of Canakinumab Prefilled Syringes or Reconstituted Lyophilizate Versus Triamcinolone Acetonide for Treating Acute Gouty Arthritis Flares in Frequently Flaring Patients
This study assessed the safety and efficacy of canakinumab pre-filled syringes in comparison to triamcinolone acetonide 40 mg and canakinumab lyophilizate in patients that have frequent flares of acute gouty arthritis.
n/a
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT01593527 -
Canakinumab in the Treatment of Gouty Arthritis Flare(s) and Prevention of New Flares in Patients With Chronic Kidney Disease
|
Phase 3 | |
| Recruiting |
NCT02545777 -
The Clinical Study on Treating Acute Gouty Arthritis Using Both Internal and External Therapy of Tonifying Spleen and Descending Turbid
|
Phase 2 | |
| Completed |
NCT00170781 -
Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout
|
Phase 4 | |
| Not yet recruiting |
NCT06273813 -
Treatment of Topical Ketorolac Gel in Acute Gouty Flare
|
Phase 1 | |
| Completed |
NCT03002974 -
A Study to Evaluate Efficacy and Safety of Anakinra in the Treatment of Acute Gouty Arthritis
|
Phase 2 | |
| Completed |
NCT01431638 -
Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients
|
Phase 3 |